English Name: Sitafloxacin
English alias: DU-6859a; Gracevit < <; 7 - ((S) - ((S) - 7 - Amino - 5 - Azaspiro [2.4] heptan - 5 - yl) - 8 - chloro - 6 - Fluoro - 1 - ((1R, 2S) - 2 - fluorocyclopropyl) - 4 - oxo - 1, 4 - dihydroquinoline - 3 - carboxylic acid; 7 - [(4S) - 4 - 4 - Amino - 6 - azo [2.4] heptan - 6 - yl] - 6 - Fluoro - 1 - ((1R, 2S) - 2 - fluorocyclopropyl) - 2 - fluorocyclopropyl) - 4 - oxo - 1, 4 - oxo - 1, 4 - dihydroquinoline[(2S) -2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic ACI D; 7-[(7S) - 7-amino-5-azaspiro [2.4] heptan-5-yl]-8-chloro-6-fluoro-1-[(2S) -2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid;
CAS: 127254-12-0
Molecular formula: C19H18ClF2N3O3
Molecular weight: 409.81400
Precise quality: 409.10000
PSA:88.56000
LogP:3.46790
Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.
河北潤民精細(xì)化學(xué)品有限公司
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!